Hjem › Aterosklerose › Arizona
Kliniske studier for Aterosklerose i Arizona
6 studier for Aterosklerose søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Smiths Medical Center, Apache Junction
- Phoenix Medical Trials, Gilbert
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
- og 5 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
RekruttererFase 3
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- AKDHC Medical, Glendale
- Kidney Disease Medical Group, Glendale
- AKDHC Medical, Phoenix
- og 2 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Gilbert
- Research Site, Gilbert
- Research Site, Peoria
- og 8 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Phoenix VA Health Care System, Phoenix, AZ, Phoenix
- Southern Arizona VA Health Care System, Tucson, AZ, Tucson
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.